RE:RE:RE:Zenabis Q4 FinancialsSure, I guess in the history of mergers there have never been a neutral and/or bad decisions according to your suggestion then? Let's look at the Hexo/Newstrike deal. Has that deal now been assessed as a good decision? FYI HIP shares are now worth a whole 13 cents but more importantly the acquisition gave Hexo more sq/ft and production which turned out to be essentially a mistake as shortly after Hexo had to readjust production and close a facility while incurring writedowns not only in capital but production. Clearly that is viewed as a poor decision and a highly costly one for Hexo and - sorry to say - the original Hip shareholders....
quinlash wrote: HEXO would have done a great deal of research on Zenabis prior to making the deal. The extent which they can research the company far exceeds what anyone on this forum would have access to. They also formed a special committee to research the deal prior to proceeding. The Board of Directors voted in favor of the deal after all of that research was done.
The benefits of doing the deal therefore can be expected to be better for the company vs. not proceeding with the deal.
If your own research does not agree then so be it however consider that HEXO likely has done much more research than you have.
GLTA
Q